Management of hospital radioactive liquid waste: treatment proposal for radioimmunoassay wastes

Radioactive liquid wastes are produced at hospitals from diagnostic and therapeutic applications of radionuclides. The most usual management of these wastes is temporary storage at the hospital for radioactivity decay and, then, discharge into sewage if not other pollutants are present in waste, always after authorization of the corresponding institution. In some cases, radioactive wastes have other hazards, such as chemical or biological ones, which can be more dangerous than radiological hazard, and do not allow direct discharge into sewage in spite of decaying activity below the clearance level. Therefore, these wastes have to be treated and condition before discharge in spite of activity decay below discharge limit. This is the case of liquid wastes from radioimmunoassay (RIA), a laboratory technique that allows to determine human substances in very low concentrations (below 10(-12) g/mL), like hormones, using I-125 as radionuclide. This study summarizes the usual management of radioactive liquid wastes from hospitals, including conventional and recent treatments applied. Furthermore, based on experimental results obtained with real RIA wastes, this work exposes a proposal of treatment with ultrafiltration and reverse osmosis membranes, and determines the most suitable application of this treatment according to radiological and operational considerations.

Automated summary

Radioactive liquid wastes produced at hospitals are usually temporarily stored for decay before discharge into sewage, but sometimes other hazards such as chemical or biological risks may require special treatment before discharge. Radioimmunoassay (RIA) wastes, a technique for detecting low concentrations of human substances, also require appropriate treatment before discharge after radioactive processing.